NO995316L - Serinproteaseinhibitorer - Google Patents
SerinproteaseinhibitorerInfo
- Publication number
- NO995316L NO995316L NO995316A NO995316A NO995316L NO 995316 L NO995316 L NO 995316L NO 995316 A NO995316 A NO 995316A NO 995316 A NO995316 A NO 995316A NO 995316 L NO995316 L NO 995316L
- Authority
- NO
- Norway
- Prior art keywords
- protease inhibitors
- serine protease
- serine
- inhibitors
- protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97201286 | 1997-05-02 | ||
| PCT/EP1998/002587 WO1998050420A1 (en) | 1997-05-02 | 1998-04-28 | Serine protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995316D0 NO995316D0 (no) | 1999-11-01 |
| NO995316L true NO995316L (no) | 1999-11-01 |
Family
ID=8228278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995316A NO995316L (no) | 1997-05-02 | 1999-11-01 | Serinproteaseinhibitorer |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6534495B1 (no) |
| EP (1) | EP0979240B1 (no) |
| JP (1) | JP2001524117A (no) |
| KR (1) | KR20010012174A (no) |
| CN (1) | CN1254345A (no) |
| AR (1) | AR012631A1 (no) |
| AT (1) | ATE264339T1 (no) |
| AU (1) | AU729910B2 (no) |
| BR (1) | BR9809342A (no) |
| CA (1) | CA2287569A1 (no) |
| DE (1) | DE69823178T2 (no) |
| DK (1) | DK0979240T3 (no) |
| ES (1) | ES2218827T3 (no) |
| HU (1) | HUP0002942A3 (no) |
| ID (1) | ID22904A (no) |
| NO (1) | NO995316L (no) |
| NZ (1) | NZ500620A (no) |
| PL (1) | PL336589A1 (no) |
| PT (1) | PT979240E (no) |
| RU (2) | RU2183642C2 (no) |
| TR (1) | TR199902692T2 (no) |
| WO (1) | WO1998050420A1 (no) |
| ZA (1) | ZA983629B (no) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9900043D0 (sv) * | 1999-01-11 | 1999-01-11 | Astra Ab | New use |
| HUP0105437A3 (en) | 1999-01-02 | 2003-03-28 | Aventis Pharma Gmbh | Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| US6344450B1 (en) * | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
| AU3731400A (en) | 1999-03-05 | 2000-09-21 | Trustees Of University Technology Corporation, The | Methods and compositions useful in inhibiting apoptosis |
| KR100767199B1 (ko) * | 1999-05-07 | 2007-10-17 | 엔싸이시브 파마슈티칼즈 인코퍼레이티드 | 인테그린이 이의 수용체에 결합하는 것을 억제하는프로판산 유도체 |
| US6723711B2 (en) | 1999-05-07 | 2004-04-20 | Texas Biotechnology Corporation | Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| US6458952B1 (en) | 1999-05-19 | 2002-10-01 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US6664255B1 (en) | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| US6653316B1 (en) | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| JP2000344739A (ja) | 1999-06-01 | 2000-12-12 | Sumitomo Chem Co Ltd | Ｎ−保護−アゼチジン−２−カルボン酸の製造方法 |
| EP1252178A1 (en) * | 1999-12-03 | 2002-10-30 | Bristol-Myers Squibb Pharma Company | Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| EP1127884A1 (en) * | 2000-02-26 | 2001-08-29 | Aventis Pharma Deutschland GmbH | Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them |
| AU2001243598A1 (en) | 2000-03-13 | 2001-09-24 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
| PT1268463E (pt) | 2000-04-05 | 2005-05-31 | Pharmacia Corp | 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao |
| EP1268428A2 (en) | 2000-04-05 | 2003-01-02 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| WO2001079155A2 (en) | 2000-04-17 | 2001-10-25 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
| CA2430037A1 (en) | 2000-11-20 | 2002-05-30 | Michael S. South | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
| WO2002060894A2 (en) | 2001-01-30 | 2002-08-08 | Bristol-Myers Squibb Company | Sulfonamide lactam inhibitors of factor xa |
| GB0119370D0 (en) * | 2001-08-08 | 2001-10-03 | Univ London | Therapeutic agent |
| DE60219926T2 (de) | 2001-08-08 | 2007-11-22 | Pentraxin Therapeutics Ltd. | Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma |
| MXPA04003170A (es) | 2001-10-03 | 2004-07-08 | Pharmacia Corp | Compuestos policiclicos, sustituidos, provisto de 5 miembros, utiles para la inhibicion selectiva de la cascada de coagulacion. |
| US6969715B2 (en) | 2001-10-03 | 2005-11-29 | Pharmacia Corporation | 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| GB0313386D0 (en) | 2003-06-10 | 2003-07-16 | Univ London | Treatment of disease |
| EP3192872A1 (en) | 2003-08-26 | 2017-07-19 | The Regents of the University of Colorado, a body corporate | Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections |
| AU2007253819B2 (en) | 2006-05-23 | 2011-02-17 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| EP2117537A1 (en) | 2007-02-09 | 2009-11-18 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| MX2011009272A (es) | 2009-03-10 | 2012-09-07 | Med Discovery S A | Uso de inhibidores de serina proteasa en el tratamiento de neutropenia. |
| SG11202008773PA (en) * | 2018-03-28 | 2020-10-29 | Blade Therapeutics Inc | Method of treating fibrotic disease |
| DE102020103516B4 (de) | 2020-02-11 | 2023-12-07 | Universität Zu Lübeck | Antivirale Wirkstoffe mit breiter Aktivität |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA86746B (en) * | 1985-02-04 | 1986-09-24 | Merrell Dow Pharma | Novel peptidase inhibitors |
| US5919765A (en) | 1995-06-07 | 1999-07-06 | Cor Therapeutics, Inc. | Inhibitors of factor XA |
| IL119466A (en) * | 1995-11-03 | 2001-08-26 | Akzo Nobel Nv | Thrombin inhibitors, their preparation and pharmaceutical compositions containing them |
| WO1998009987A1 (en) * | 1996-09-06 | 1998-03-12 | Biochem Pharma, Inc. | Lactam inhibitors of thrombin |
-
1998
- 1998-04-28 CA CA002287569A patent/CA2287569A1/en not_active Abandoned
- 1998-04-28 WO PCT/EP1998/002587 patent/WO1998050420A1/en active IP Right Grant
- 1998-04-28 PL PL98336589A patent/PL336589A1/xx unknown
- 1998-04-28 NZ NZ500620A patent/NZ500620A/xx unknown
- 1998-04-28 RU RU99125967/04A patent/RU2183642C2/ru active
- 1998-04-28 PT PT98924265T patent/PT979240E/pt unknown
- 1998-04-28 CN CN98804741A patent/CN1254345A/zh active Pending
- 1998-04-28 US US09/403,856 patent/US6534495B1/en not_active Expired - Fee Related
- 1998-04-28 JP JP54771598A patent/JP2001524117A/ja active Pending
- 1998-04-28 DE DE69823178T patent/DE69823178T2/de not_active Expired - Fee Related
- 1998-04-28 ID IDW991290A patent/ID22904A/id unknown
- 1998-04-28 AU AU76520/98A patent/AU729910B2/en not_active Ceased
- 1998-04-28 DK DK98924265T patent/DK0979240T3/da active
- 1998-04-28 EP EP98924265A patent/EP0979240B1/en not_active Expired - Lifetime
- 1998-04-28 KR KR19997010123A patent/KR20010012174A/ko not_active Application Discontinuation
- 1998-04-28 HU HU0002942A patent/HUP0002942A3/hu unknown
- 1998-04-28 ES ES98924265T patent/ES2218827T3/es not_active Expired - Lifetime
- 1998-04-28 TR TR1999/02692T patent/TR199902692T2/xx unknown
- 1998-04-28 BR BR9809342-8A patent/BR9809342A/pt not_active IP Right Cessation
- 1998-04-28 AT AT98924265T patent/ATE264339T1/de not_active IP Right Cessation
- 1998-04-29 ZA ZA983629A patent/ZA983629B/xx unknown
- 1998-04-30 AR ARP980102014A patent/AR012631A1/es unknown
-
1999
- 1999-11-01 NO NO995316A patent/NO995316L/no not_active Application Discontinuation
-
2002
- 2002-02-14 RU RU2002104026/15A patent/RU2002104026A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT979240E (pt) | 2004-08-31 |
| ZA983629B (en) | 1998-11-04 |
| DE69823178D1 (de) | 2004-05-19 |
| NZ500620A (en) | 2000-10-27 |
| NO995316D0 (no) | 1999-11-01 |
| HUP0002942A3 (en) | 2001-12-28 |
| CN1254345A (zh) | 2000-05-24 |
| ATE264339T1 (de) | 2004-04-15 |
| DE69823178T2 (de) | 2005-06-23 |
| ES2218827T3 (es) | 2004-11-16 |
| HUP0002942A2 (hu) | 2001-01-29 |
| BR9809342A (pt) | 2000-07-04 |
| DK0979240T3 (da) | 2004-07-26 |
| KR20010012174A (ko) | 2001-02-15 |
| ID22904A (id) | 1999-12-16 |
| RU2183642C2 (ru) | 2002-06-20 |
| EP0979240A1 (en) | 2000-02-16 |
| AU729910B2 (en) | 2001-02-15 |
| TR199902692T2 (xx) | 2000-07-21 |
| WO1998050420A1 (en) | 1998-11-12 |
| US6534495B1 (en) | 2003-03-18 |
| JP2001524117A (ja) | 2001-11-27 |
| RU2002104026A (ru) | 2004-04-27 |
| CA2287569A1 (en) | 1998-11-12 |
| AR012631A1 (es) | 2000-11-08 |
| EP0979240B1 (en) | 2004-04-14 |
| AU7652098A (en) | 1998-11-27 |
| PL336589A1 (en) | 2000-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69823178D1 (de) | Serine protease inhibitoren | |
| NO995433D0 (no) | Protease-inhibitorer | |
| NO992734D0 (no) | Serin-protease inhibitorer | |
| NO20012980D0 (no) | Proteaseinhibitorer | |
| NO983688D0 (no) | Serin-protease-inhibitorer | |
| PT936912E (pt) | Inibidores de cisteina protease | |
| DE69830410D1 (de) | Meta-benzamidinderivate als serinprotease-inhibitoren | |
| NO981938D0 (no) | Proteaseinhibitorer | |
| NO20011966D0 (no) | Serin-protease-inhibitor | |
| ID25897A (id) | Variant-variant protease tersubstitusi banyak | |
| NO996578D0 (no) | Urokinase-inhibitorer | |
| DE69730871D1 (de) | Serine-protease-inhibitoren | |
| NO995434D0 (no) | Proteaseinhibitorer | |
| DE69807845D1 (de) | Sulfamide-metalloprotease inhibitoren | |
| NO995435D0 (no) | Protease-inhibitorer | |
| ATE221080T1 (de) | Serine-protease-inhibitoren | |
| NO995268D0 (no) | Proteaseinhibitorer | |
| NO20011388D0 (no) | Hydroksamat-inneholdende cystein- og serinproteasehemmere | |
| GB9800817D0 (en) | Serine protease inhibitors | |
| MA26429A1 (fr) | Inhibiteurs de protease | |
| NO994415D0 (no) | HIV proteaseinhibitorer | |
| BR9612344A (pt) | Inibidores de proteases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |